(0)

Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Hotel Pullman Brussels Midi

Jun 06, 2016 9:00 AM - Jun 06, 2016 5:00 PM

Place Victor Horta 1, 1060 Brussels, Belgium

DIA-TOPRA Workshop on Falsified Medicines

This conference will take stock of where we stand in the EU on falsified medicines and paint the landscape of the global issue. The speakers will present the approaches of the Member States on the implementation of the new legislation, and the impact and achievements of the concerned stakeholders such as industry, patients, pharmacies and distributors who have worked independently and together to find solutions.

Overview

Download Programme

This conference will take stock of where we stand in the EU on falsified medicines and paint the landscape of the global issue. The speakers will present the approaches of the Member States on the implementation of the new legislation, and the impact and achievements of the concerned stakeholders such as industry, patients, pharmacies and distributors who have worked independently and together to find solutions. The key messages of the meeting will be presented in a paper outlining the positive benefits until now and also the challenges yet to be addressed.

Please register for the event at TOPRA website.

Featured

Want to learn more about DIA-TOPRA Workshop on Falsified Medicines? You've come to the right site!

Continuing-Education

Learn more

What you will learn

  • Understand the nature of the issue at the EU and global level comprehensively
  • Hear from the Member States on their approaches on the endorsement and implementation
  • Discuss how to navigate the various systems and exchange experiences on challenges and solutions
  • Address the challenges linked to the whole supply chain by bringing the stakeholders to the same table and understand the challenges each stakeholder group is addressing

Who should attend?

The meeting is intended for professionals working with the implementation of the new rules in various points of the supply chain. Regulators or policymakers involved in the endorsement of the rules at national level and professionals participating in the stakeholder groups of manufacturers, market authorisation holders, wholesalers, pharmacy owners and managers and patient representatives would find the meeting interesting as well.

Program Committee

  • Ursula Busse, PhD, MBA
    Ursula Busse, PhD, MBA Head of Regulatory Affairs
    Tigen Pharma SA, Switzerland
  • Gerald W. Heddell
    Gerald W. Heddell Director, Inspection Enforcement & Standards Division
    Medicines and Healthcare products Regulatory Agency (MHRA), United Kingdom
  • Susanne Keitel, DrSc, RPh
    Susanne Keitel, DrSc, RPh Director
    European Directorate for the Quality of Medicines & Healthcare (EDQM), France
  • Syed Qadri
    Syed Qadri Lead Consultant
    GENPACT Pharmalink, United Kingdom

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.